Of the U.S. biopharmaceutical companies currently developing treatments or vaccines targeting the COVID-19 infection caused by coronavirus, Vir Biotechnology Inc.'s shares have increased by 279 percent as they are in the midst of preclinical testing monoclonal antibodies as a treatment for this disease. This statistic shows the year-to-date stock performance of select biopharmaceutical companies working on COVID-19 treatments or vaccines in the U.S. as of March 11, 2020.
Year-to-date stock performance of select U.S. biopharmaceutical companies working on COVID-19 treatments or vaccines as of March 11, 2020
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
MarketWatch. (March 11, 2020). Year-to-date stock performance of select U.S. biopharmaceutical companies working on COVID-19 treatments or vaccines as of March 11, 2020 [Graph]. In Statista. Retrieved November 21, 2024, from https://www.statista.com/statistics/1103563/year-to-date-stock-performance-biopharma-covid-treatment/
MarketWatch. "Year-to-date stock performance of select U.S. biopharmaceutical companies working on COVID-19 treatments or vaccines as of March 11, 2020." Chart. March 11, 2020. Statista. Accessed November 21, 2024. https://www.statista.com/statistics/1103563/year-to-date-stock-performance-biopharma-covid-treatment/
MarketWatch. (2020). Year-to-date stock performance of select U.S. biopharmaceutical companies working on COVID-19 treatments or vaccines as of March 11, 2020. Statista. Statista Inc.. Accessed: November 21, 2024. https://www.statista.com/statistics/1103563/year-to-date-stock-performance-biopharma-covid-treatment/
MarketWatch. "Year-to-date Stock Performance of Select U.S. Biopharmaceutical Companies Working on Covid-19 Treatments or Vaccines as of March 11, 2020." Statista, Statista Inc., 11 Mar 2020, https://www.statista.com/statistics/1103563/year-to-date-stock-performance-biopharma-covid-treatment/
MarketWatch, Year-to-date stock performance of select U.S. biopharmaceutical companies working on COVID-19 treatments or vaccines as of March 11, 2020 Statista, https://www.statista.com/statistics/1103563/year-to-date-stock-performance-biopharma-covid-treatment/ (last visited November 21, 2024)
Year-to-date stock performance of select U.S. biopharmaceutical companies working on COVID-19 treatments or vaccines as of March 11, 2020 [Graph], MarketWatch, March 11, 2020. [Online]. Available: https://www.statista.com/statistics/1103563/year-to-date-stock-performance-biopharma-covid-treatment/
